Therapeutic targets in alcohol-associated liver disease: progress and challenges
Alcohol-associated liver disease (ALD) is a complex disease with rapidly increasing prevalence. Although there are promising therapeutic targets on the horizon, none of the newer targets is currently close to an Food and Drug Administration approval. Strategies are needed to overcome challenges in s...
Main Authors: | Ayooluwatomiwa Deborah Adekunle, Adeyinka Adejumo, Ashwani K. Singal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-05-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/17562848231170946 |
Similar Items
-
Editorial: Alcohol-associated liver disease—From pathogenesis to treatment
by: Kusum K. Kharbanda, et al.
Published: (2022-10-01) -
3427 Racial and Gender Differences in Trends, Prevalence, and Outcomes for Non-alcoholic Fatty Liver Disease Hospitalizations in the US
by: Adeyinka Charles Adejumo, et al.
Published: (2019-03-01) -
3429 Inpatient Palliative Care Consultation Improves Readmissions in End-Stage Liver Disease
by: Adeyinka Charles Adejumo
Published: (2019-03-01) -
Alcohol‐Associated Liver Disease Before and After COVID‐19—An Overview and Call for Ongoing Investigation
by: Andrew M. Moon, et al.
Published: (2021-09-01) -
Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
by: Adeyinka Charles Adejumo, et al.
Published: (2017-01-01)